Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn E Dale

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Drug Discovery Today|September 15, 2004
Opening the bottlenecksGlenn E Dale
Journal of Structural Biology|April 30, 2003
The protein as a variable in protein crystallizationGlenn E Dale, Christian Oefner, Allan D'Arcy
Antimicrobial Agents and Chemotherapy|February 14, 2018
Pharmacokinetics and Safety of Intravenous Murepavadin Infusion in Healthy Adult Subjects Administered Single and Multiple Ascending DosesAchim Wach, Klaus Dembowsky, Glenn E Dale
Expert Review of Anti-Infective Therapy|February 17, 2018
Murepavadin: a new antibiotic class in the pipelineIgnacio Martin-Loeches, Glenn E Dale, Antoni Torres
Acta Crystallographica. Section D, Biological Crystallography|May 16, 2006
Mapping the active site of Escherichia coli malonyl-CoA-acyl carrier protein transacylase (FabD) by protein crystallographyChristian Oefner, Henk Schulz, Allan D'Arcy, et al.
Analytical Biochemistry|July 5, 2003
A continuous coupled enzyme assay for bacterial malonyl-CoA:acyl carrier protein transacylase (FabD)Juliette Molnos, Rana Gardiner, Glenn E Dale, et al.
Acta Crystallographica. Section D, Biological Crystallography|August 21, 2007
Structural studies of a bifunctional inhibitor of neprilysin and DPP-IVChristian Oefner, Sabine Pierau, Henk Schulz, et al.
Journal of Molecular Biology|November 11, 2008
Structure of human endothelin-converting enzyme I complexed with phosphoramidonHenk Schulz, Glenn E Dale, Yasmin Karimi-Nejad, et al.
Drug Discovery Today|July 9, 2021
Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infectionsVincent Trebosc, Christian Kemmer, Sergio Lociuro, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 23, 2009
Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureusChristian Oefner, Sandro Parisi, Henk Schulz, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Drug Discovery Today|September 15, 2004
Opening the bottlenecksGlenn E Dale
Journal of Structural Biology|April 30, 2003
The protein as a variable in protein crystallizationGlenn E Dale, Christian Oefner, Allan D'Arcy
Antimicrobial Agents and Chemotherapy|February 14, 2018
Pharmacokinetics and Safety of Intravenous Murepavadin Infusion in Healthy Adult Subjects Administered Single and Multiple Ascending DosesAchim Wach, Klaus Dembowsky, Glenn E Dale
Expert Review of Anti-Infective Therapy|February 17, 2018
Murepavadin: a new antibiotic class in the pipelineIgnacio Martin-Loeches, Glenn E Dale, Antoni Torres
Acta Crystallographica. Section D, Biological Crystallography|May 16, 2006
Mapping the active site of Escherichia coli malonyl-CoA-acyl carrier protein transacylase (FabD) by protein crystallographyChristian Oefner, Henk Schulz, Allan D'Arcy, et al.
Analytical Biochemistry|July 5, 2003
A continuous coupled enzyme assay for bacterial malonyl-CoA:acyl carrier protein transacylase (FabD)Juliette Molnos, Rana Gardiner, Glenn E Dale, et al.
Acta Crystallographica. Section D, Biological Crystallography|August 21, 2007
Structural studies of a bifunctional inhibitor of neprilysin and DPP-IVChristian Oefner, Sabine Pierau, Henk Schulz, et al.
Journal of Molecular Biology|November 11, 2008
Structure of human endothelin-converting enzyme I complexed with phosphoramidonHenk Schulz, Glenn E Dale, Yasmin Karimi-Nejad, et al.
Drug Discovery Today|July 9, 2021
Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infectionsVincent Trebosc, Christian Kemmer, Sergio Lociuro, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 23, 2009
Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureusChristian Oefner, Sandro Parisi, Henk Schulz, et al.
Pageof 4